Concin H, Nagel G. Preventing overdiagnosis in mammography screening - a public health perspective.
Horm Mol Biol Clin Investig 2017;
32:/j/hmbci.2017.32.issue-1/hmbci-2017-0040/hmbci-2017-0040.xml. [PMID:
29252194 DOI:
10.1515/hmbci-2017-0040]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/09/2017] [Accepted: 07/26/2017] [Indexed: 11/15/2022]
Abstract
Prevention and management of breast cancer in order to provide high quality health care is an important public health issue. The existence of overdiagnosis for breast-cancer was controversial for a long time but is now broadly accepted. Overdiagnosis is defined as the diagnosis of "disease" that will never cause symptoms or death during a patient's ordinarily expected lifetime. Estimates of the overdiagnosis rate for breast cancer range up to 54% of screen-detected localized tumors. New approaches, such as the identification of high risk groups or primary prevention approaches could be more relevant from the public health perspective.
Collapse